Evercore ISI lowered the firm’s price target on Moderna (MRNA) to $50 from $60 and keeps an In Line rating on the shares. The firm is updating ...
We recently published a list of Top 10 AI News You Shouldn’t Miss. In this article, we are going to take a look at where ...
The Nasdaq 100 Index has nearly doubled since the start of 2023, adding $14 trillion in value in the process. Evercore ISI’s ...
Evercore ISI raised the firm’s price target on Verizon (VZ) to $44 from $42 and keeps an In Line rating on the shares. Verizon exited 2024 with ...
Akero Therapeutics has hit a home run, reporting statistically significant results in two key 96-week metabolic ...
Evercore EVR underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish ...
Evercore ISI added United Parcel Service ( NYSE: UPS) to its Tactical Outperform list ahead of the parcel delivery giant's ...
Shane Gong, managing director and head of Evercore’s Asia-Pacific private capital advisory team, is in the process of leaving ...
Evercore ISI analyst Duane Pfennigwerth maintained a Hold rating on American Airlines (AAL – Research Report) on January 24 and set a price ...
Netflix is set to report its quarterly earnings with analysts expecting modest revenue and subscriber growth, amid mixed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback